| |
| Issue |
Title |
| |
| No 10 (2015) |
CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES REPLACEMENT |
Abstract
PDF (Rus)
|
|
S. M. Arslanbekova, D. A. Sychev, K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, N. M. Magomedova, E. Z. Golukhova |
| |
| No 10 (2015) |
THE “PROTOCOL” STUDY: PRELIMINARY RESULTS |
Abstract
PDF (Rus)
|
|
E. M. Zelenskaya, A. I. Subbotovskaya, V. I. Ganyukov, N. A. Kochergin, V. B. Barbarich, N. O. Saraeva, A. V. Vybivantseva, K. A. Apartsin, G. I. Lifshitz |
| |
| No 10 (2015) |
GENE CYP2C19 POLYMORPHISM G681A INFLUENCE ON THE EFFICACY OF CLOPIDOGREL IN ENDOVASCULAR TREATMENT OF ISCHEMIC HEART DISEASE COMORBID WITH TYPE 2 DIABETES |
Abstract
PDF (Rus)
|
|
A. N. Repin, T. N. Sergienko, E. F. Muslimova, E. F. Afanasyev |
| |
| 1 - 3 of 3 Items |
|
